SCHEMBL3483199

SCHEMBL3483199

N#Cc1cccc(C(NS(=O)(=O)c2cc3cc(OCCN)c(OCCN)cc3s2)P(=O)(O)O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3480911 0.94 CACNA1B (0.33)
SCHEMBL3483911 0.80 TRPV4 (0.31)
SCHEMBL3483247 0.78 AR (0.33)
SCHEMBL3483723 0.76 TRPV4 (0.31)
Trifluoroacetic Acid SCHEMBL3484268 0.76 CACNA1B (0.31)
SCHEMBL14942987 0.76 CA2 (0.31)
SCHEMBL3483243 0.75 TRPV4 (0.31)
SCHEMBL3483812 0.75 CA2 (0.32)
Trifluoroacetic Acid SCHEMBL3480353 0.75 AR (0.31)
SCHEMBL3483412 0.74 AR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049200-B1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC (CA) 2015-04-29 EP claimed
US-8440643-B2 Inhibitors of beta-lactamase METHYLGENE INC. (CA) 2013-05-14 US claimed
US-20100279983-A1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC. 2010-11-04 US claimed
EP-2049200-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MethylGene Inc. (CA) 2009-04-22 EP claimed
WO-2008073142-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK & CO., INC. (US) 2008-06-19 WO claimed